Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier.
Ontology highlight
ABSTRACT: The proinflammatory cytokine Interleukin-1 (IL-1), with its two isoforms α and β, has important roles in multiple pathogenic processes in the central nervous system. The present study aimed to evaluate and compare the blood-to-brain distribution of anakinra (IL-1 receptor antagonist), bermekimab (IL-1α antagonist) and canakinumab (IL-1β antagonist). A human in vitro model of the blood-brain barrier derived from human umbilical cord blood stem cells was used, where isolated CD34+ cells co-cultured with bovine pericytes were matured into polarized brain-like endothelial cells. Transport rates of the three test items were evaluated after 180 min incubation at concentrations 50, 250 and 1250 nM in a transwell system. We report herein that anakinra passes the human brain-lik
SUBMITTER: Sjostrom EO
PROVIDER: S-EPMC8474601 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA